Concepedia

Andrew Georgiou

AG

22

Publications

2.7K

Citations

21

H-Index

1980

Active since

Affiliations

University College London(Current)

CRUK Lung Cancer Centre of Excellence

The Francis Crick Institute

London Cancer

Royal Marsden NHS Foundation Trust

Andrew Georgiou is an author at University College London specializing in medicine, cell biology, and gene expression.

ORCID

Top concepts

Publications per year

1980–2022

22

Publications

22

Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

Frederick Arce Vargas, Andrew J.S. Furness, Kevin Litchfield et al. · Cancer Cell · 2018 · 563 citations · Full text

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon et al. · Immunity · 2017 · 425 citations · Full text

Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer

Kroopa Joshi, Marc Robert de Massy, Mazlina Ismail et al. · Nature Medicine · 2019 · 208 citations · Full text

, , +11

CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

Isabelle Solomon, Maria Amann, Anne Goubier et al. · Nature Cancer · 2020 · 184 citations · Full text

, , +10

Variant histone H3.3 marks promoters of transcriptionally active genes during mammalian cell division

Cheok-man Chow, Andrew Georgiou, Henrietta Szutorisz et al. · EMBO Reports · 2005 · 162 citations · Full text

, , +13

Rows per page

1–5 of 22